Gill Farrar

¹⁸F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

Rik Vandenberghe, Koen Van Laere, Adrian Ivanoiu et al. · Annals of Neurology · 2010 · 636 citations

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection

Miloš D. Ikonomović, Christopher Buckley, Kerstin Heurling et al. · Acta Neuropathologica Communications · 2016 · 98 citations · Full text

Performance of [¹⁸F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease

Stephen Salloway, José E. Gámez, Upinder Singh et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 91 citations · Full text

[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

Juha O. Rinne, Dean F. Wong, David A. Wolk et al. · Acta Neuropathologica · 2012 · 81 citations

Neuroimaging Biomarkers, Medicine, Normal Pressure Hydrocephalus +10

Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study

Bernard Hanseeuw, Vincent Malotaux, Laurence Dricot et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 79 citations · Full text